{
    "id": "5fdb2e60a43ad3127800000c",
    "question": "Is the TFR1 gene dispensable for erythropoiesis?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to understand the role of the TFR1 gene in erythropoiesis. The TFR1 gene encodes the transferrin receptor 1, which plays a crucial role in iron uptake and utilization in erythroid cells. According to document [18], Tf-bound Fe3+ from enterocytes and macrophages binds to receptors (TfR) on erythroblasts and other Fe-requiring cells and is taken up by receptor-mediated endocytosis. The absence or dysfunction of TFR1 would likely disrupt iron uptake and utilization in erythroid cells, leading to impaired erythropoiesis. Therefore, it is unlikely that the TFR1 gene is dispensable for erythropoiesis. On the other hand, document [25] does not explicitly state that the TFR1 gene is essential for erythropoiesis, but it does mention that erythropoietin stimulates the production of erythrocytes, and document [18] indicates that Tf-bound Fe3+ is taken up by receptor-mediated endocytosis on TfR. Hence, it can be inferred that TFR1 plays a critical role in erythropoiesis and is not dispensable.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "InternalMed_Harrison_23351",
            "title": "InternalMed_Harrison",
            "content": "Ineffective Erythropoiesis During erythroid maturation, small amounts 3 (MRP3) and subjected to reuptake into the hepatocyte by the of hemoglobin may be lost at the time of nuclear extrusion, and a fracsinusoidal membrane uptake transporters organic anion transport tion of developing erythroid cells is destroyed within the marrow. protein 1B1 (OATP1B1) and OATP1B3."
        },
        {
            "id": "InternalMed_Harrison_4441",
            "title": "InternalMed_Harrison",
            "content": "The critical elements of erythropoiesis\u2014EPO production, iron availability, the proliferative capacity of the bone marrow, and effective maturation of red cell precursors\u2014are used for the initial classification of anemia (see below)."
        },
        {
            "id": "Histology_Ross_1445",
            "title": "Histology_Ross",
            "content": "(CSFs), that influence their proliferation and maturation into a specific lineage. Development of Erythrocytes (Erythropoiesis) Erythrocyte development starts from CMP cells that, under the influence of erythropoietin, IL-3, and IL-4, differentiate to MEP cells. Expression of transcription factor GATA-1is required for the terminal differentiation of MEP cells to definitive erythroid cell lineage. Under GATA-1 influence, MEP cells transform into erythropoietin-sensitive erythrocyte-committed progenitors (ErPs or CFU-E) that give rise to the proerythroblast. The first microscopically recognizable precursor cell in erythropoiesis is called the proerythroblast."
        },
        {
            "id": "Cell_Biology_Alberts_6248",
            "title": "Cell_Biology_Alberts",
            "content": "An important example of the latter is a protein called Steel or Stem Cell Factor (SCF ). This is expressed both in the bone marrow stroma (where it helps to define the stem-cell niche) and along pathways of migration, and it occurs both in a membrane-bound and a soluble form. It binds to a receptor tyrosine kinase called Kit, and it is required during development for guidance and survival not only of hematopoietic cells but also of other migratory cell types\u2014specifically, germ cells and pigment cells. erythropoiesis depends on the hormone erythropoietin The best understood of the CSFs that act as hormones is the glycoprotein erythropoietin, which is produced in the kidneys and regulates erythropoiesis, the formation of red blood cells, to which we now turn."
        },
        {
            "id": "InternalMed_Harrison_8404",
            "title": "InternalMed_Harrison",
            "content": "the erythropoietin hypersensitivity, erythropoietin-independent erythroid colony formation, rapid terminal differentiation, increase in Bcl-XL expression, and apoptosis resistance in the absence of erythropoietin that characterize the in vitro behavior of PV erythroid progenitor cells."
        },
        {
            "id": "Pharmacology_Katzung_3687",
            "title": "Pharmacology_Katzung",
            "content": "Erythropoietin stimulates erythroid proliferation and differentiation by interacting with erythropoietin receptors on red cell progenitors. The erythropoietin receptor is a member of the JAK/ STAT superfamily of cytokine receptors that use protein phosphorylation and transcription factor activation to regulate cellular function (see Chapter 2). Erythropoietin also induces release of reticulocytes from the bone marrow. Endogenous erythropoietin is produced primarily in the kidney. In response to tissue hypoxia, more erythropoietin is produced through an increased rate of transcription of the erythropoietin gene. This results in correction of the anemia, provided that the bone marrow response is not impaired by red cell nutritional deficiency (especially iron deficiency), primary bone marrow disorders (see below), or bone marrow suppression from drugs or chronic diseases."
        },
        {
            "id": "InternalMed_Harrison_29016",
            "title": "InternalMed_Harrison",
            "content": "The HFE gene encodes a 343-amino-acid protein that is structurally related to MHC class I proteins (HFE). The basic defect in HFE-associated hemochromatosis is a lack of cell surface expression of HFE (due to the C282Y mutation). The normal (wild-type) HFE protein forms a complex with \u03b22-microglobulin and transferrin receptor 1 (TfR1). The C282Y mutation completely abrogates this interaction. As a result, the mutant HFE protein remains trapped intracellularly, reducing TfR1-mediated iron uptake by the intestinal crypt cell. This impaired TfR1-mediated iron uptake leads to upregulation of the divalent metal transporter (DMT1) on the brush border of the villus cells, causing inappropriately increased intestinal iron absorption (Fig. 428-1). In advanced disease, the body may contain 20 g or more of iron that is deposited mainly in parenchymal cells of the liver, pancreas, and heart. Iron may be increased 50to 100-fold in the liver and pancreas"
        },
        {
            "id": "Cell_Biology_Alberts_6252",
            "title": "Cell_Biology_Alberts",
            "content": "The cells that respond to erythropoietin can be identified by culturing bone marrow cells in a semisolid matrix in the presence of erythropoietin. In a few days, colonies of about 60 erythrocytes appear, each founded by a single committed erythroid progenitor cell. This progenitor depends on erythropoietin for its survival as well as its proliferation. It does not yet contain hemoglobin, and it is derived from an earlier type of committed erythroid progenitor whose survival and proliferation are governed by other factors."
        },
        {
            "id": "Pathology_Robbins_2706",
            "title": "Pathology_Robbins",
            "content": "Fig. 12.5 ), a phenomenon termed ineffective erythropoiesis, and the few red cells that are produced have a shortened life span. Ineffective hematopoiesis has another untoward effect; it is associated with an inappropriate increase in the absorption of dietary iron, which without medical intervention inevitably leads to iron overload. The increased iron absorption is caused by inappropriately low hepcidin, which is a negative regulator of iron absorption (see later). Unlike \u03b2-thalassemia, \u03b1-thalassemia is caused mainly by deletions involving one or more of the \u03b1-globin genes. The severity of the disease is proportional to the number of \u03b1-globin genes that are deleted ("
        },
        {
            "id": "Pediatrics_Nelson_3161",
            "title": "Pediatrics_Nelson",
            "content": "erythroid line and is made by the juxtaglomerular apparatus of the kidney in response to local tissue hypoxia. Thenormally high hemoglobin level of the fetus is a result of fetal erythropoietin production in the liver in response tolow Po2 in utero. Erythropoietin leads to production of theerythroid colony-forming unit. The earliest recognizableerythroid cell is the erythroblast, which forms eight or moredaughter cells. The RBC nucleus becomes gradually pyknotic and eventually is extruded. The cell is then releasedfrom the marrow as a reticulocyte that maintains residual mitochondrial and protein synthetic capacity. Thesehighly specialized RBC precursors are engaged primarily inthe production of globin chains, glycolytic enzymes, and heme. Iron is taken up via transferrin receptors and incorporated into the heme ring, which combines with globinchains synthesized within the immature RBC. When themessenger RNA and mitochondria are gone from the RBC,heme or protein synthesis is no longer"
        },
        {
            "id": "InternalMed_Harrison_5350",
            "title": "InternalMed_Harrison",
            "content": "pathways is mediated by alterations in gene expression. The regulation of the differentiation by soluble factors and cell-cell communications within the bone marrow niche are still being defined. The transcription factors that characterize particular cell transitions are illustrated on the arrows; the soluble factors that contribute to the differentiation process are in blue. This picture is a simplification of the process. Active research is revealing multiple discrete cell types in the maturation of B cells and T cells and has identified cells that are biased toward one lineage or another (rather than uncommitted) in their differentiation. EPO, erythropoi- etin; RBC, red blood cell; SCF, stem cell factor; TPO, thrombopoietin."
        },
        {
            "id": "InternalMed_Harrison_7976",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 126-2 Laboratory studies in the evolution of iron deficiency. Measurements of marrow iron stores, serum ferritin, and total iron-binding capacity (TIBC) are sensitive to early iron-store depletion. Iron-deficient erythropoiesis is recognized from additional abnormalities in the serum iron (SI), percent transferrin saturation, the pattern of marrow sideroblasts, and the red blood cell (RBC) protoporphyrin level. Patients with iron-deficiency anemia demonstrate all the same abnormalities plus hypochromic microcytic anemia. (From RS Hillman, CA Finch: The Red Cell Manual, 7th ed. Philadelphia, F.A.Davis and Co., 1996, with permission.) range, hemoglobin synthesis is unaffected despite the dwindling iron stores. Once the transferrin saturation falls to 15\u201320%, hemoglobin synthesis becomes impaired. This is a period of iron-deficient erythropoiesis. Careful evaluation of the peripheral blood smear reveals the first appearance of microcytic cells, and if the laboratory technology is"
        },
        {
            "id": "InternalMed_Harrison_8030",
            "title": "InternalMed_Harrison",
            "content": "The LCR controlling the \u03b1-globin gene cluster is modulated by a SWI/SNF-like protein called ATRX; this protein appears to influence chromatin remodeling and DNA methylation. The association of \u03b1 thalassemia with mental retardation and myelodysplasia in some families appears to be related to mutations in the ATRX pathway. This pathway also modulates genes specifically expressed during erythropoiesis, such"
        },
        {
            "id": "InternalMed_Harrison_4436",
            "title": "InternalMed_Harrison",
            "content": "red cell production can increase fourto fivefold within a 1to 2-week period, but only in the presence of adequate nutrients, especially iron. The functional capacity of the erythron, therefore, requires normal renal production of EPO, a functioning erythroid marrow, and an adequate supply of substrates for hemoglobin synthesis. A defect in any of these key components can lead to anemia. Generally, anemia is recognized in the laboratory when a patient\u2019s hemoglobin level or hematocrit is reduced below an expected value (the normal range). The likelihood and severity of anemia are defined based on the deviation of the patient\u2019s hemoglobin/hematocrit from values expected for ageand sex-matched normal subjects. The hemoglobin concentration in adults has a Gaussian distribution. The and FOG-1 (friend of GATA-1) transcription factors (Chap. 89e)."
        },
        {
            "id": "InternalMed_Harrison_29021",
            "title": "InternalMed_Harrison",
            "content": "Secondary iron overload with deposition in parenchymal cells occurs in chronic disorders of erythropoiesis, particularly in those due to defects in hemoglobin synthesis or ineffective erythropoiesis such as sideroblastic anemia and thalassemia (Chap. 127). In these disorders, iron absorption is increased. Moreover, these patients require blood transfusions and are frequently treated inappropriately with iron. PCT, a disorder characterized by a defect in porphyrin biosynthesis (Chap. 430), can also be associated with excessive parenchymal iron deposits. The magnitude of the iron load in PCT is usually insufficient to produce tissue damage. However, some patients with PCT also have mutations in the HFE gene, and some have associated hepatitis C virus (HCV) infection. Although the relationship between these disorders remains to be clarified, iron overload accentuates the inherited enzyme deficiency in PCT and should be avoided along with other agents (alcohol, estrogens, haloaromatic"
        },
        {
            "id": "InternalMed_Harrison_29090",
            "title": "InternalMed_Harrison",
            "content": "In the erythron, novel regulatory mechanisms allow for the production of the very large amounts of heme needed for hemoglobin synthesis. The response to stimuli for hemoglobin synthesis occurs during cell differentiation, leading to an increase in cell number. In contrast, the erythroid-specific ALA synthase 2 is expressed at higher levels than the housekeeping enzyme, and erythroid-specific control mechanisms regulate other pathway enzymes as well as iron transport into erythroid cells. Separate erythroid-specific and nonerythroid or \u201chousekeeping\u201d transcripts are known for the first four enzymes in the pathway. As noted above, housekeeping and erythroid-specific ALA synthases are encoded by genes on different chromosomes, but for each of the next three genes in the pathway, both erythroid and nonerythroid transcripts are transcribed by alternative promoters from their single respective genes (Table 430-2)."
        },
        {
            "id": "InternalMed_Harrison_4437",
            "title": "InternalMed_Harrison",
            "content": "Following lineage commitment, hematopoietic progenitor and precur sor cells come increasingly under the regulatory influence of growth factors and hormones. For red cell production, erythropoietin (EPO) is the primary regulatory hormone. EPO is required for the maintenance of committed erythroid progenitor cells that, in the absence of the hormone, undergo programmed cell death (apoptosis). The regulated process of red cell production is erythropoiesis, and its key elements are illustrated in Fig. 77-1. In the bone marrow, the first morphologically recognizable ery throid precursor is the pronormoblast. This cell can undergo four to five cell divisions, which result in the production of 16\u201332 mature red cells. With increased EPO production, or the administration of EPO as a drug, early progenitor cell numbers are amplified and, in turn, give rise to increased numbers of erythrocytes. The regulation of EPO production itself is linked to tissue oxygenation."
        },
        {
            "id": "InternalMed_Harrison_8078",
            "title": "InternalMed_Harrison",
            "content": "Hypochromia and microcytosis characterize all forms of \u03b2 thalassemia because of the reduced amounts of hemoglobin tetramers (Fig. 127-5). In heterozygotes (\u03b2 thalassemia trait), this is the only abnormality seen. Anemia is minimal. In more severe homozygous states, unbalanced \u03b1and \u03b2-globin accumulation causes accumulation of highly insoluble unpaired \u03b1 chains. They form toxic inclusion bodies that kill developing erythroblasts in the marrow. Few of the proerythroblasts beginning erythroid maturation survive. The surviving RBCs bear a burden of inclusion bodies that are detected in the spleen, shortening the RBC life span and producing severe hemolytic anemia. The resulting profound anemia stimulates erythropoietin release and compensatory erythroid hyperplasia, but the marrow response is sabotaged by the ineffective erythropoiesis. Anemia persists. Erythroid hyperplasia can become exuberant and produce masses of extramedullary erythropoietic tissue in the liver and spleen."
        },
        {
            "id": "Biochemistry_Lippincott_1409",
            "title": "Biochemistry_Lippinco",
            "content": "Recycling: Macrophages phagocytose old and/or damaged red blood cells (RBC), freeing heme Fe that is sent out of the cells via ferroportin, oxidized by ceruloplasmin, and transported by Tf as described above. This recycled Fe meets ~90% of our daily need, which is predominantly for erythropoiesis. 3. Uptake: Tf-bound Fe3+ from enterocytes and macrophages binds to receptors (TfR) on erythroblasts and other Fe-requiring cells and is taken up by receptor-mediated endocytosis. The Fe3+ is released from Tf for use (or stored on ferritin), and the TfR (and Tf) is recycled in a process similar to the receptor-mediated endocytosis seen with low-density lipoprotein particles (see p. 231). [Note: Regulation of the translation of the messenger RNA for ferritin and the TfR by iron regulatory proteins and iron-responsive elements is discussed on p. 474.] 4."
        },
        {
            "id": "Histology_Ross_1439",
            "title": "Histology_Ross",
            "content": "FIGURE 10.18 \u2022 Dynamics of hemopoiesis in embryonic and fetal life. During embryonic and fetal life, erythrocytes are formed in several organs. Essentially, three major organs involved in hemopoiesis can be sequentially identified: The yolk sac in the early developmental stages of the embryo; the liver during the second trimester of pregnancy; and the bone marrow during the third trimester. The spleen participates to a very limited degree during the second trimester of pregnancy. At birth, most hemopoiesis occurs in the red bone marrow, as it does in the adult. \u0081 Megakaryocyte/erythrocyte progenitor (MEP) cells: These bipotential stem cells give rise to monopotent megakaryocyte-committed progenitor cells (MKP or CFU-Meg) and other monopotent erythrocyte-committed progenitor cells (ErP or CFU-E) that give rise to the erythrocyte lineage."
        },
        {
            "id": "InternalMed_Harrison_29140",
            "title": "InternalMed_Harrison",
            "content": "Diagnosis Bone marrow examination reveals hypercellularity with a left shift and megaloblastic erythropoiesis with an abnormal maturation. A variety of Prussian blue-staining sideroblasts are observed. Levels of urinary porphyrin precursors and of both urinary and fecal porphyrins are normal. The activity of erythroid ALA synthase 2 is decreased in bone marrow, but this enzyme is difficult to measure in the presence of the normal ALA synthase 1 housekeeping enzyme. Definitive diagnosis requires the demonstration of mutations in the erythroid ALAS2 gene. The severe anemia may respond to pyridoxine supplementation. This cofactor is essential for ALA synthase activity, and mutations in the pyridoxine binding site of the enzyme have been found in The Porphyrias 2532 several responsive patients. Cofactor supplementation may make it possible to eliminate or reduce the frequency of transfusion. Unresponsive patients may be transfusion-dependent and require chelation therapy."
        },
        {
            "id": "Pediatrics_Nelson_3157",
            "title": "Pediatrics_Nelson",
            "content": "The hematopoietic cells consist of the following: 1. Small compartment of pluripotential progenitor stem cells that resemble small lymphocytes and are capable of forming all myeloid elements 2. Large compartment of committed, proliferating cells of myeloid, erythroid, and megakaryocytic lineage 3. Large compartment of postmitotic maturing cells(Fig. 149-1) The bone marrow is the major storage organ for mature neutrophils and contains about seven times the intravascular pool of neutrophils. It contains 2.5 to 5 times as many cells of myeloid lineage as cells of erythroid lineage. Smaller numbers of megakaryocytes, plasma cells, histiocytes, lymphocytes, and stromal cells are also stored in the marrow. Erythropoiesis (red blood cell [RBC] production) iscontrolled by erythropoietin, a glycoprotein that stimulatesprimitive pluripotential stem cells to differentiate along the"
        },
        {
            "id": "Histology_Ross_1450",
            "title": "Histology_Ross",
            "content": "FIGURE 10.21 \u2022 Electron micrograph of a polychromatophilic erythrocyte (reticulocyte). The nucleus is no longer present, and the cytoplasm shows the characteristic fimbriated processes that occur just after nuclear extrusion. Mitochondria are still present, as are early and late endosomes and ribosomes. 16,500. (Courtesy of Dr. Dorothea Zucker-Franklin.) the new erythrocytes can also be demonstrated with special stains that cause the polyribosomes to clump and form a reticular network. Consequently, polychromatophilic erythrocytes are also (and more commonly) called reticulocytes. In normal blood, reticulocytes constitute about 1% to 2% of the total erythrocyte count. However, if increased numbers of erythrocytes enter the bloodstream (as during increased erythropoiesis to compensate for blood loss), the number of reticulocytes increases. Kinetics of Erythropoiesis Mitoses occur in proerythroblasts, basophilic erythroblasts, and polychromatophilic erythroblasts."
        },
        {
            "id": "Biochemistry_Lippincott_1653",
            "title": "Biochemistry_Lippinco",
            "content": "a. Iron metabolism: Transferrin (Tf) is a plasma protein that transports iron. Tf binds to cell-surface receptors (transferrin receptors [TfR]) that get internalized and provide cells, such as erythroblasts, with iron. The mRNA for the TfR has several cis-acting iron-responsive elements (IRE) in its 3\u2032-UTR. IRE have a short stem-loop structure that can be bound by trans-acting iron regulatory proteins (IRP), as shown in Figure 33.14. When the iron concentration in the cell is low, the IRP bind to the 3\u2032-IRE and stabilize the mRNA for TfR, allowing TfR synthesis. When intracellular iron levels are high, the IRP dissociate. The lack of IRP bound to the mRNA hastens its destruction, resulting in decreased TfR synthesis. [Note: The mRNA for ferritin, an intracellular protein of iron storage, has a single IRE in its 5\u2032-UTR. When iron levels in the cell are low, IRP bind the 5\u2032-IRE and prevent the use of the mRNA, and less ferritin is made. When iron accumulates in the cell, the IRP"
        },
        {
            "id": "Pediatrics_Nelson_3211",
            "title": "Pediatrics_Nelson",
            "content": "Clinical Manifestations. Signs and symptoms of \u03b2thalassemia major result from the combination of chronic hemolytic disease, decreased or absent production of normal hemoglobin A, and ineffective erythropoiesis. The anemia is severe and leads to growth failure and high-output heart failure. Ineffective erythropoiesis causes increased expenditure of energy and expansion of the bone marrow cavities of all bones, leading to osteopenia, pathologic fractures, extramedullary erythropoiesis with resultant hepatosplenomegaly, and an increase in the rate of iron absorption."
        },
        {
            "id": "InternalMed_Harrison_8376",
            "title": "InternalMed_Harrison",
            "content": "has been linked to mutations and chromosome abnormalities in some specific MDS syndromes. The 5q\u2013 deletion leads to heterozygous loss of a ribosomal protein gene that is also mutant in Diamond-Blackfan anemia, and both are characterized by deficient erythropoiesis. An immune pathophysiology may underlie trisomy 8 MDS, in which patients often experience improved blood counts after immunosuppressive therapy; there is T cell activity directed to hematopoietic progenitors, which the cytogenetically aberrant clone resists. However, in general for MDS, the role of the immune system and its cells and cytokines; the role of the hematopoietic stem cell niche, the microenvironment, and cell-cell interactions; the fate of normal cells in the Darwinian competitive environment of the dysplastic marrow; and how mutant cells produce marrow failure in MDS are not well understood."
        },
        {
            "id": "InternalMed_Harrison_8087",
            "title": "InternalMed_Harrison",
            "content": "The diagnosis of \u03b2-thalassemia major is readily made during childhood on the basis of severe anemia accompanied by the characteristic signs of massive ineffective erythropoiesis: hepatosplenomegaly, profound microcytosis, a characteristic blood smear (Fig. 127-5), and elevated levels of HbF, HbA2, or both. Many patients require chronic hypertransfusion therapy designed to maintain a hematocrit of at least 27\u201330% so that erythropoiesis is suppressed. Splenectomy is required if the annual transfusion requirement (volume of RBCs per kilogram of body weight per year) increases by >50%. Folic acid supplements may be useful. Vaccination with Pneumovax in anticipation of eventual splenectomy is advised, as is close monitoring for infection, leg ulcers, and biliary tract disease. Many patients develop endocrine deficiencies as a result of iron overload. Early endocrine evaluation is required for glucose intolerance, thyroid dysfunction, and delayed onset of puberty or secondary sexual"
        },
        {
            "id": "InternalMed_Harrison_8079",
            "title": "InternalMed_Harrison",
            "content": "Massive bone marrow expansion deranges growth and development. Children develop characteristic \u201cchipmunk\u201d facies due to maxillary marrow hyperplasia and frontal bossing. Thinning and pathologic fracture of long bones and vertebrae may occur due to cortical invasion by erythroid elements and profound growth retardation. Hemolytic anemia causes hepatosplenomegaly, leg ulcers, gallstones, and high-output congestive heart failure. The conscription of caloric resources to support erythropoiesis leads to inanition, susceptibility to infection, endocrine dysfunction, and in the most severe cases, death during the first decade of life. Chronic transfusions with RBCs improve oxygen delivery, suppress the excessive ineffective erythropoiesis, and prolong life, but the inevitable side effects, notably iron overload, often prove fatal by age 30 years."
        },
        {
            "id": "Cell_Biology_Alberts_6251",
            "title": "Cell_Biology_Alberts",
            "content": "senescent erythrocytes in each of us each day. Young erythrocytes actively protect themselves from this fate: they have a protein on their surface that binds to an inhibitory receptor on macrophages and thereby prevents their phagocytosis. A lack of oxygen or a shortage of erythrocytes stimulates specialized cells in the kidney to synthesize and secrete increased amounts of erythropoietin into the bloodstream. The erythropoietin, in turn, boosts the production of erythrocytes. The effect is rapid: the rate of release of new erythrocytes into the bloodstream rises steeply 1\u20132 days after an increase in erythropoietin levels in the bloodstream. Clearly, the hormone must act on cells that are close precursors of the mature erythrocytes."
        },
        {
            "id": "First_Aid_Step1_435",
            "title": "First_Aid_Step1",
            "content": "\u201cYou\u2019re always somebody\u2019s type! (blood type, that is)\u201d \u201cAll the soarings of my mind begin in my blood.\u201d \u201cThe best blood will at some time get into a fool or a mosquito.\u201d When studying hematology, pay close attention to the many cross connections to immunology. Make sure you master the different types of anemias. Be comfortable interpreting blood smears. When reviewing oncologic drugs, focus on mechanisms and adverse effects rather than details of clinical uses, which may be lower yield. Please note that solid tumors are covered in their respective organ system chapters. Fetal erythropoiesis Fetal erythropoiesis occurs in: Young Liver Synthesizes Blood. Bone marrow (18 weeks to adult) Embryonic globins: \u03b6 and \u03b5. Fetal hemoglobin (HbF) =\u03b1\u03b3 From fetal to adult hemoglobin: 2 2. Adult hemoglobin (HbA ) =\u03b1\u03b2 Alpha Always; Gamma Goes, Becomes Beta. 1 22."
        },
        {
            "id": "Pediatrics_Nelson_3164",
            "title": "Pediatrics_Nelson",
            "content": "During the first few months of postnatal life, rapid growth, shortened RBC survival, and cessation of erythropoiesis cause a gradual decline in hemoglobin levels, with a nadir at 8 to 10 weeks of life. This so-called physiologic nadir is accentuated in premature infants. Erythropoietin is produced in response to the decline in hemoglobin and decreased oxygen delivery. Erythropoiesis subsequently resumes with an increase in the reticulocyte count. The hemoglobin level gradually increases, accompanied by synthesis of increasing amounts of hemoglobin A. By 6 months of age in healthy infants, only trace gamma chain synthesis occurs."
        },
        {
            "id": "InternalMed_Harrison_8008",
            "title": "InternalMed_Harrison",
            "content": "Endocrine Deficiency States The difference in the levels of hemoglobinIL-6 mediated pathway, and acts to suppress iron absorption and iron between men and women is related to the effects of androgen andrelease from storage sites. The overall result is a chronic hypoproliferaestrogen on erythropoiesis. Testosterone and anabolic steroids augtive anemia with classic changes in iron metabolism. The anemia is furment erythropoiesis; castration and estrogen administration to malesther compounded by a mild to moderate shortening in red cell survival."
        }
    ],
    "scores": [
        0.030386905184278445,
        0.029248114350842874,
        0.029014189771800595,
        0.02665007948026816,
        0.026247544725805594,
        0.02508078404055649,
        0.023984200702839062,
        0.02392708515958772,
        0.0231078061723223,
        0.021845841487638438,
        0.021691432764630342,
        0.0194004144004144,
        0.019327731092436976,
        0.018653479090751345,
        0.01838731443994602,
        0.017820370663709804,
        0.01722753485655887,
        0.017125292740046837,
        0.01702405099971023,
        0.01584627862000125,
        0.01549599138446811,
        0.015495559926098098,
        0.015449773323789072,
        0.015338122933059643,
        0.014910163582729955,
        0.014623587794319503,
        0.014492753623188406,
        0.01427555374923796,
        0.014250493096646943,
        0.014087301587301586,
        0.01384949896010588,
        0.013523100115278887
    ]
}